今日共收錄 7 篇迷幻研究文獻。
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V · Development and clinical evaluation of a nanoemulsion for buccal delivery of cannabis extract in refractory chronic pain.
Cannabinoid-based therapies have gained increasing attention for the management of chronic and treatment-resistant pain, although their clinical application is limited by the poor aqueous solubility a
The International journal on drug policy · Implementation factors shaping British Columbia's drug decriminalization pilot: A systematic review with narrative synthesis.
BACKGROUND: In January 2023, British Columbia (BC) became the first Canadian province to implement a legally sanctioned drug decriminalization policy, removing criminal penalties for adults possessing
Progress in neuro-psychopharmacology & biological psychiatry · MDMA as an early post-trauma intervention in a translational animal model of PTSD.
Post-traumatic stress disorder (PTSD) remains difficult to prevent after trauma, highlighting the need for early interventions that reduce the risk of chronic symptom development. This controlled stud
Addictive behaviors reports · Substance use and mental health outcomes among gay and bisexual men in South Korea: a cross-sectional study.
PURPOSE: This study investigated the prevalence of substance use among gay and bisexual men in South Korea and examined its association with mental health outcomes. METHODS: Data were drawn from a nat
Molecular psychiatry · Time-dependent effects of rapid-acting antidepressants in iPSC-derived neurons from treatment-resistant depression and healthy volunteers.
Rapid-acting antidepressants like ketamine and serotonergic psychedelics show promise for treatment-resistant depression (TRD), but the molecular mechanisms that contribute to their therapeutic effect
Neuropsychopharmacology reports
Psychedelics such as psilocybin and lysergic acid diethylamide (LSD) exert hallucinogenic effects through stimulation of serotonin 5-HT2A receptors (5
Journal of affective disorders
OBJECTIVE: Little is known about esketamine's effectiveness for patients with major depressive disorder (MDD) comorbid substance use disorders (SUD).